Solène Cadiou

Dr. Solène Cadiou

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
AGAlicia Guillien
Alicia Guillien
SCSolène Cadiou
Solène Cadiou
RSRémy Slama
Rémy Slama
VSValérie Siroux
Valérie Siroux
Asthma is a widespread respiratory disease caused by complex contribution from genetic, environmental and behavioral factors. For several decades, its sensitivity to environmental factors has been investigated in single exposure (or single family of exposures) studies, which might be a narrow approach to tackle the etiology of such a complex multifactorial disease. The emergence of the exposome concept, introduced by C. Wild (2005), offers an alternative to address exposure–health associations. After presenting an overview of the exposome concept, we discuss different statistical approaches used to study the exposome–health associations and review recent studies linking multiple families of exposures to asthma-related outcomes. The few studies published so far on the association between the exposome and asthma-related outcomes showed differences in terms of study design, population, exposome definition and statistical methods used, making their results difficult to compare. Regarding statistical methods, most studies applied successively univariate (Exposome-Wide Association Study (ExWAS)) and multivariate (adjusted for co-exposures) (e.g., Deletion–Substitution–Addition (DSA) algorithm) regression-based models. This latest approach makes it possible to assess associations between a large set of exposures and asthma outcomes. However, it cannot address complex interactions (i.e., of order ≥3) or mixture effects. Other approaches like cluster-based analyses, that lead to the identification of specific profiles of exposure at risk for the studied health-outcome, or mediation analyses, that allow the integration of information from intermediate biological layers, could offer a new avenue in the understanding of the environment–asthma association. European projects focusing on the exposome research have recently been launched and should provide new results to help fill the gap that currently exists in our understanding of the effect of environment on respiratory health.

1 August 2021 in Environment International
Verified
Journal Article
Open access
SCSolène Cadiou
Solène Cadiou
XBXavier Basagaña
Xavier Basagaña
JGJuan R. Gonzalez
Juan R. Gonzalez
JLJohanna Lepeule
Johanna Lepeule
MVMartine Vrijheid
Martine Vrijheid
RSRémy Slama
Rémy Slama
Challenges in the assessment of the health effects of the exposome, defined as encompassing all environmental exposures from the prenatal period onwards, include a possibly high rate of false positive signals. It might be overcome using data dimension reduction techniques. Data from the biological layers lying between the exposome and its possible health consequences, such as the methylome, may help reducing exposome dimension. We aimed to quantify the performances of approaches relying on the incorporation of an intermediary biological layer to relate the exposome and health, and compare them with agnostic approaches ignoring the intermediary layer. We performed a Monte-Carlo simulation, in which we generated realistic exposome and intermediary layer data by sampling with replacement real data from the Helix exposome project. We generated a Gaussian outcome assuming linear relationships between the three data layers, in 2381 scenarios under five different causal structures, including mediation and reverse causality. We tested 3 agnostic methods considering only the exposome and the health outcome: ExWAS (for Exposome-Wide Association study), DSA, LASSO; and 3 methods relying on an intermediary layer: two implementations of our new oriented Meet-in-the-Middle (oMITM) design, using ExWAS and DSA, and a mediation analysis using ExWAS. Methods' performances were assessed through their sensitivity and FDP (False-Discovery Proportion). The oMITM-based methods generally had lower FDP than the other approaches, possibly at a cost in terms of sensitivity; FDP was in particular lower under a structure of reverse causality and in some mediation scenarios. The oMITM-DSA implementation showed better performances than oMITM-ExWAS, especially in terms of FDP. Among the agnostic approaches, DSA showed the highest performance. Integrating information from intermediary biological layers can help lowering FDP in studies of the exposome health effects; in particular, oMITM seems less sensitive to reverse causality than agnostic exposome-health association studies.

5 November 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
CRCarlos Ruiz-Arenas
Carlos Ruiz-Arenas
CHCarles Hernandez-Ferrer
Carles Hernandez-Ferrer
MVMarta Vives-Usano
Marta Vives-Usano
SMSergi Marí
Sergi Marí
IQInés Quintela
Inés Quintela
MBMariona Bustamante
Mariona Bustamante
Background: The identification of expression quantitative trait methylation (eQTMs), defined as associations between DNA methylation levels and gene expression, might help the biological interpretation of epigenome-wide association studies (EWAS). We aimed to identify autosomal cis eQTMs in children’s blood, using data from 832 children of the Human Early Life Exposome (HELIX) project. Methods: Blood DNA methylation and gene expression were measured with the Illumina 450K and the Affymetrix HTA v2 arrays, respectively. The relationship between methylation levels and expression of nearby genes (1 Mb window centered at the transcription start site, TSS) was assessed by fitting 13.6 M linear regressions adjusting for sex, age, cohort, and blood cell composition. Results: We identified 39,749 blood autosomal cis eQTMs, representing 21,966 unique CpGs (eCpGs, 5.7% of total CpGs) and 8,886 unique transcript clusters (eGenes, 15.3% of total transcript clusters, equivalent to genes). In 87.9% of these cis eQTMs, the eCpG was located at <250 kb from eGene’s TSS; and 58.8% of all eQTMs showed an inverse relationship between the methylation and expression levels. Only around half of the autosomal cis-eQTMs eGenes could be captured through annotation of the eCpG to the closest gene. eCpGs had less measurement error and were enriched for active blood regulatory regions and for CpGs reported to be associated with environmental exposures or phenotypic traits. 40.4% of eQTMs had at least one genetic variant associated with methylation and expression levels. The overlap of autosomal cis eQTMs in children’s blood with those described in adults was small (13.8%), and age-shared cis eQTMs tended to be proximal to the TSS and enriched for genetic variants. Conclusions: This catalogue of autosomal cis eQTMs in children’s blood can help the biological interpretation of EWAS findings and is publicly available at https://helixomics.isglobal.org/ . Funding: The study has received funding from the European Community’s Seventh Framework Programme (FP7/2007-206) under grant agreement no 308333 (HELIX project); the H2020-EU.3.1.2. - Preventing Disease Programme under grant agreement no 874583 (ATHLETE project); from the European Union’s Horizon 2020 research and innovation programme under grant agreement no 733206 (LIFECYCLE project), and from the European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL and Instituto de Salud Carlos III) under the grant agreement no AC18/00006 (NutriPROGRAM project). The genotyping was supported by the project PI17/01225, funded by the Instituto de Salud Carlos III and co-funded by European Union (ERDF, “A way to make Europe”) and the Centro Nacional de Genotipado-CEGEN (PRB2-ISCIII).

4 April 2026
Verified
Thesis
Closed access
SCSolène Cadiou
Solène Cadiou
Influence de l'exposome sur la santé : apport des données de haute dimension de méthylation de l'ADN: Contexte : L'exposome est défini comme l’ensemble des expositions environnementales reçues au cours de la vie (dont la vie prénatale). La puissance statistique limitée et le taux élevé de faux positifs des études actuelles sont deux défis majeurs pour la caractérisation de ses effets sur la santé. Les faux-positifs peuvent notamment être dus à de la causalité inverse. Pour faire face à ces défis, affiner les méthodes statistiques est utile, mais l'utilisation d'information biologique, par exemple provenant de couches intermédiaires telle la méthylation de l'ADN, peut aussi contribuer à réduire la dimension du problème, et les faux positifs liés à la causalité inverse.Objectifs : Notre objectif principal est d’identifier des stratégies pour limiter les faux positifs dans les études sur l’exposome, en particulier en intégrant des informations a priori provenant du méthylome, et d’appliquer ces stratégies à l’étude de l’influence de l'environnement sur la santé de l’enfant. Nous avons également cherché à illustrer d’autres enjeux des études sur l’exposome liés à l’instabilité des modèles.Méthodes : Nous avons d'abord mis en œuvre deux approches "Meet-in-the-Middle orientées" (oMITM) pour caractériser le lien entre exposome et santé de l'enfant (indice de masse corporelle, IMC et fonction pulmonaire) dans les cohortes Helix (1173 mères-enfants) ; l'approche comprenait 3 étapes : a) identification de CpG indépendamment associés aux expositions et à la santé en utilisant des connaissances a priori et/ou des régressions linéaires univariées ; b) identification par régression linéaire des expositions associées à au moins un de ces CpG, constituant un exposome réduit ; c) test de leur association avec la santé. Nous avons ensuite réalisé une simulation de Monte-Carlo pour caractériser la pertinence du design oMITM sous différentes structures causales. Nous avons simulé un exposome, une couche intermédiaire et un évènement de santé à partir des données Helix en postulant des relations linéaires entre les couches. La magnitude des liens variait, générant 2281 scénarios sous 5 structures causales différentes, dont une de causalité inverse. Pour chaque scénario, 100 jeux de données étaient générés et 6 méthodes testées : 3 ignorant le méthylome ("approches agnostiques" : ExWAS ; DSA ; LASSO) et 3 l’utilisant (deux implémentations d’oMITM et une analyse de médiation). Les performances étaient évaluées par leur sensibilité et spécificité. Nous avons aussi effectué une étude de simulation pour évaluer l'instabilité de certaines méthodes agnostiques, en particulier le LASSO.Résultats : Les approches oMITM sur les données Helix ont identifié une exposition, le niveau postnatal de cuivre dans le sang, associé à un IMC accru et à une fonction pulmonaire diminuée. Une ExWAS entre exposome et IMC dans HELIX a identifié 18 autres expositions (lipophiles), dont l'association avec l'IMC pourrait de ce fait être due à de la causalité inverse. L'étude de simulation a montré que, par rapport aux autres approches, le design oMITM peut éviter certains faux positifs dans au moins une situation de causalité inverse et augmenter la spécificité lorsque la couche intermédiaire médie une partie de l'effet de l'exposome sur la santé, ceci à un coût en terme de sensibilité. L’implémentation oMITM-DSA montrait de meilleures performances qu’oMITM-ExWAS. La deuxième simulation a montré que l'étape de stabilisation du modèle est cruciale lors de l'utilisation d'algorithmes d'apprentissage agnostique tels LASSO, car elle en modifie les performances.Discussion : L'utilisation de méthodes statistiques complexes adaptées à des données de dimensions intermédiaires ou élevées, ou la prise en compte de connaissances biologiques, pourraient aider à limiter les faux positifs dans les études sur l’exposome. Nous avons proposé un design, oMITM, qui est moins sujet au biais de causalité inverse que les approches agnostiques avec un coût en termes de sensibilité.

27 July 2026 in medRxiv
Verified
Preprint
Open access
PDF file
SCSolène Cadiou
Solène Cadiou
EKEva König
Eva König
AMAlessia Mapelli
Alessia Mapelli
GPGiulia Pontali
Giulia Pontali
DGDariush Ghasemi-Semeskandeh
Dariush Ghasemi-Semeskandeh
ABAdam S Butterworth
Adam S Butterworth
Circulating plasma proteins are key biomarkers and therapeutic targets, now measurable at scale through high-throughput technologies, yet whether expanding proteomics platforms beyond the classical plasma secretome enhances genetic discovery and causal inference remains poorly understood. Here, we use an expanded SomaScan 7k platform to map the genetic architecture of a broader segment of the plasma proteome and to evaluate how proteome expansion affects pQTL discovery, causal inference and therapeutic target prioritisation. After quality control, we analysed 7,144 aptamers targeting 6,267 proteins in the harmonised dataset of two European cohorts: INTERVAL (n = 9,251 participants) and CHRIS (n = 4,194), and conducted genome-wide pQTL association analyses followed by meta-analysis. We identified 7,870 significant pQTLs (P-value < 1.26 x 10E-11; 1,784 cis, 6,086 trans), of which 2,704 (34%) associations were not reported in five prior large-scale pQTL studies. Newly assessed proteins, which accounted for 53% (1,422/2,704) of the novel associations, were less likely to harbour cis-pQTLs associations (15%) than those in the previous platform version (28%), consistent with their lower expected plasma concentrations and predominantly intracellular localisation. Colocalization analyses revealed widespread sharing of genetic signals across proteins and characterised 22 pleiotropic trans-regulatory hotspots accounting for 68% of all trans-pQTLs. Through two-sample Mendelian randomization analyses on 2,003 phenotypes from the Million Veteran Program, UK Biobank, and FinnGen (combined N > 1.2 million), we identified 6,340 genetically supported protein-trait associations, highlighting disease mechanisms and potential therapeutic opportunities beyond currently drug-targeted circulating proteins. Together, these findings provide a systematic view of the genetic architecture of the expanded plasma proteome and demonstrate that plasma proteome expansion reveals genetically anchored disease biology beyond the classical secretome, while exposing inherent biological and technical constraints of studying low-abundance intracellular proteins in circulation.